发明名称 Compositions and methods for treating and preventing pathologies including cancer
摘要 Compositions and methods of treating anemia, cancer, AIDS, or severe beta -chain hemoglobinopathies by administering a therapeutically effective amount of phenylacetate or pharmaceutically acceptable derivatives thereof or derivatives thereof alone or in combination or in conjunction with other therapeutic agents including retinoids, hydroxyurea, and flavonoids. Intravesicle methods of treatment of cancers phenylacetate. Pharmacologically-acceptable salts alone or in combinations and methods of preventing AIDS and malignant conditions, and inducing cell differentiation are also aspects of this invention. A product as a combined preparation of phenylacetate and a retinoid, hydroxyurea, or flavonid (or other mevalonate pathway inhibitor) for simultaneous, separate, or sequential use in treating a neoplastic condition in a subject. Methods of modulating lipid metabolism and/or reducing serum triglycerides in a subject using phenylacetate.
申请公布号 US5843994(A) 申请公布日期 1998.12.01
申请号 US19950478264 申请日期 1995.06.07
申请人 THE UNITED STATES OF AMERICA AS REPRESENETED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES 发明人 SAMID, DVORIT
分类号 A61K31/353;A61K;A61K31/035;A61K31/07;A61K31/12;A61K31/17;A61K31/19;A61K31/192;A61K31/20;A61K31/22;A61K31/35;A61K31/365;A61K31/70;A61K31/7072;A61K31/7076;A61K38/21;A61K38/22;A61K45/00;A61K45/06;A61P1/04;A61P3/00;A61P3/06;A61P3/08;A61P3/10;A61P7/00;A61P9/00;A61P13/02;A61P13/08;A61P13/10;A61P13/12;A61P15/00;A61P17/00;A61P17/02;A61P19/02;A61P25/00;A61P27/02;A61P29/00;A61P31/04;A61P31/12;A61P31/18;A61P35/00;A61P37/02;A61P37/04;A61P37/06;A61P43/00;(IPC1-7):A61K31/21;A01N47/40 主分类号 A61K31/353
代理机构 代理人
主权项
地址